Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/2015
03/05/2015WO2015031425A1 Compound of glycosaminoglycan and its preparation method as well as application
03/05/2015WO2015031396A1 Pharmaceutical compositions comprising macrolide diastereomers, methods of their synthesis and therapeutic uses
03/05/2015WO2015031295A1 Ido inhibitors
03/05/2015WO2015029967A1 Antibody titer-increasing agent using lactic acid bacterium
03/05/2015WO2015028850A1 Novel cytotoxic agents for conjugation of drugs to cell binding molecule
03/05/2015WO2015028848A1 Bicyclic heterocyclic compounds as multi-kinase inhibitors
03/05/2015WO2015027949A1 Application of deuterated fumaric acid derivatives in treatment of multiple sclerosis
03/05/2015WO2015027906A1 Bifunctional fusion protein, preparation method therefor, and use thereof
03/04/2015EP2843051A1 Anti-human cd69 antibody, and use thereof for medical purposes
03/04/2015EP2843048A1 NOVEL INTEGRIN alpha9beta1 LIGAND AND USES THEREOF
03/04/2015EP2842961A1 New carbamate glycolipid and use thereof
03/04/2015EP2842957A1 Method for extracting and separating ginkgolides
03/04/2015EP2842955A1 Trk-INHIBITING COMPOUND
03/04/2015EP2842937A1 Amine compound and use thereof for medical purposes
03/04/2015EP2842933A1 Mixtures of cannabinoid compounds, their preparation and use
03/04/2015EP2842570A1 Compositions and methods for the prevention and treatment of autoimmune conditions
03/04/2015EP2842568A1 Pharmaceutical composition for treating and/or preventing type i diabetes and application thereof
03/04/2015EP2842433A1 Food for nutritional therapy of aids
03/04/2015EP2841559A1 Glycoengineered outer membrane vesicles and use thereof as vaccines
03/04/2015EP2841453A1 Humanized and chimeric anti-factor c3 antibodies and uses thereof
03/03/2015US8968763 Block biodegradable copolymers for medical devices
02/2015
02/26/2015WO2015027124A1 Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors
02/26/2015WO2015027021A1 Imide and acylurea derivatives as modulators of the glucocorticoid receptor
02/26/2015WO2015026205A1 Composition for preventing and treating immune diseases, containing daurinol compound as active ingredient
02/26/2015WO2015025871A1 Methods for evaluating and screening s1p1 receptor agonists
02/26/2015WO2015025810A1 Production method and cryopreservation method for amniotic mesenchymal cell composition, and therapeutic agent
02/26/2015WO2015025059A1 Cd105-negative multipotent mesenchymal stromal cells
02/26/2015WO2015024512A1 Use of icaritin in preparation of drugs for treatment of diseases related to flt-3
02/26/2015WO2015024218A1 Pharmaceutical composition, preparation method therefor and use thereof
02/26/2015WO2015024148A1 Vaccine from cell factor mutant of heterogeneous animal
02/26/2015WO2015024060A1 Immunoreceptor modulation for treating cancer and viral infections
02/26/2015WO2015024042A1 Immunoreceptor modulation for treating cancer and viral infections
02/25/2015EP2840083A1 Nitrogenated bicyclic aromatic heterocyclic compound
02/25/2015EP2838919A1 Anti-mige antibodies that bind to the junction between ch4 and c epsilon mx domains
02/25/2015EP2838895A1 Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
02/25/2015EP2838614A1 Compounds and methods for regulating integrins
02/25/2015EP2838560A2 Methods of treating ankylosing spondylitis using il-17 antagonists
02/25/2015EP2838543A1 Immunostimulatory compositions and methods of manufacture
02/25/2015EP2838532A2 Method treating scleroderma
02/24/2015US8962795 Factor H binding peptides and uses thereof
02/24/2015US8962596 5,7-substituted-imidazo[1,2-C]pyrimidines as inhibitors of JAK kinases
02/24/2015US8962032 Modulator
02/24/2015US8961989 Methods for producing an immune response to tuberculosis
02/24/2015CA2681756C Inhibitors of bruton's tyrosine kinase
02/24/2015CA2663537C Il-17 receptor a antigen binding proteins
02/24/2015CA2627423C Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors
02/24/2015CA2479288C Process for producing cytotoxic lymphocyte
02/19/2015WO2015023972A1 Treatment of graft rejection by administering a complement inhibitor to an organ prior to transplant
02/19/2015WO2015023790A1 Compositions and methods for treating chronic urticaria
02/19/2015WO2015023165A1 Inflammation-controlling composite and stabilized mesenchymal stem cells having optimized immunity control function by blocking stat3 signal molecule
02/19/2015WO2015023147A1 Mtor/stat3 signal inhibitor-treated mesenchymal stem cell having immunomodulatory activity, and cell therapy composition comprising same, for preventing or treating immune disorders
02/19/2015WO2015022326A1 Peptides as active agents for treating primary graft dysfunction
02/19/2015WO2015021904A1 Method for synthesizing glatiramer acetate
02/19/2015WO2015021632A1 Astragalus membranaceus seed extract and use thereof for preparing animal feed and foods
02/18/2015EP2837632A1 Compound jk12a and preparation thereof
02/18/2015EP2837627A1 Amidopyridine derivative, and use thereof
02/18/2015EP2837383A1 Immunity-inducing agent
02/18/2015EP2836507A2 Sortase- modified vhh domains and uses thereof
02/18/2015EP2836487A1 Heterocyclic compounds and uses thereof
02/18/2015EP2836208A1 Composition for the treatment of inflammatory and immune disorders
02/18/2015EP2591799A9 Cancer peptide vaccine
02/17/2015US8957065 Fused pyrimidine derivatives for inhibition of tyrosine kinase activity
02/17/2015US8956662 Phenylephrine pharmaceutical formulations and compositions for colonic absorption
02/17/2015CA2776522C Development of a preventive vaccine for filovirus infection in primates
02/17/2015CA2710977C 2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin d analogs
02/17/2015CA2635623C Anti-cd19 antibodies with reduced immunogenicity
02/17/2015CA2541006C Tim-3 polypeptides
02/12/2015WO2015020567A1 Laminaria angustata-based product for enhancing regeneration and proliferation of cells, method of producing and use the same
02/12/2015WO2015019347A1 Girk as a therapeutic target of immune disorders and a marker of b cell subtypes
02/12/2015WO2015018475A1 Piperidine urea derivatives
02/12/2015WO2015018333A1 Inhibitors of bruton's tyrosine kinase
02/12/2015US20150047064 INHIBITING GENE EXPRESSION WITH dsRNA
02/11/2015EP2834274A1 Recombinant papaya mosaic virus coat proteins and uses thereof in influenza vaccines
02/11/2015EP2834271A1 Humanized and chimeric anti-factor bb antibodies and uses thereof
02/11/2015EP2833914A1 Improved adjuvant system for oral vaccine adminstration
02/11/2015EP2833896A2 Compositions and treatment methods for mesenchymal stem cell-induced immunoregulation
02/11/2015EP2833884A1 Use of ccr3-inhibitors
02/11/2015EP2412797A9 Process for producing lactic acid bacterium having enhanced immunomodulating activity
02/11/2015CN104350070A 调节免疫反应的组合物和方法 Adjust the compositions and methods of immune response
02/11/2015CN104350053A 杂芳族甲基环胺衍生物 Heteroaromatic methyl cyclic amine derivative
02/11/2015CN104349785A 人淋巴系器官源性抑制性基质细胞的分离和用途 Human lymphoid organs, stromal cell-derived suppressor separation and uses
02/11/2015CN104341502A 低免疫原性抗TNF-α全人源单抗及其应用 Low immunogenicity fully human anti-TNF-α monoclonal antibody and its application
02/11/2015CN104341451A 新磷酸酯化合物、其制备方法及含有它们的药物组合物 New phosphate compounds, their preparation and pharmaceutical compositions containing them
02/11/2015CN104341437A 含有双环基团的syk抑制剂 Containing bicyclic group of syk inhibitor
02/11/2015CN104341395A 新的吡咯化合物、它们的制备方法和含有它们的药物组合物 The new pyrrole compounds, their preparation and pharmaceutical compositions containing them
02/11/2015CN104341371A 3-[5-(2-氟苯基)-[1,2,4]噁二唑-3-基]-苯甲酸的晶型 3- [5- (2-fluorophenyl) - [1,2,4] oxadiazol-3-yl] - benzoic acid in crystalline form
02/11/2015CN104338131A 芪黄肽多糖注射液 Qihuang polysaccharide peptide injection
02/11/2015CN104338130A 芪黄肽注射液的制备方法 Qihuang peptide injection preparation
02/11/2015CN104338129A 雷帕霉素作为疫苗佐剂的用途及制备方法 Use and preparation of rapamycin as a vaccine adjuvant
02/11/2015CN104338111A 一种治疗荨麻疹的药物 A therapeutic drug urticaria
02/11/2015CN104338106A 一种治疗过敏性鼻炎的汤剂药物及制备方法 A treatment for allergic rhinitis drug decoction and preparation methods
02/11/2015CN104338043A 一种提高免疫力的药物及其制备方法 An immunity and preparation methods to improve
02/11/2015CN104338031A 生白方中药饮片组合制剂、制备方法及组合包装 Chinese Herbal Medicine Health White combination preparation, preparation method and composition of packaging
02/11/2015CN104337996A 一种具有降脂减肥和调节免疫功能的中药组合物 Having a lipid-lowering diet and regulation of the immune function of the herbal composition
02/11/2015CN104337976A 一种提升畜禽免疫力的中药组合物 Way to boost the immune system of traditional Chinese medicine composition for livestock
02/11/2015CN104337960A 止咳化痰露 Refreshment dew
02/11/2015CN104337908A 一种治疗顽固性、过敏性咽喉炎的中药 An intractable allergic laryngitis medicine treatment
02/11/2015CN104337871A 一种降糖胶囊 Hypoglycemic capsules
02/11/2015CN104337819A 白桦脂酸衍生物在制备抑制t细胞分化的药物中的应用 Betulinic acid derivative in the preparation of cell differentiation inhibiting drug t Applications
02/11/2015CN104337774A 一种地氯雷他定颗粒剂的制备方法 A way that he will be prepared loratadine granules
1 2 3 4 5 6 7 8 9 10 11 ... 1172